Gene · 719
Papers2,264
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,264
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Mechanism of Chaishao Kaiyu Decoction in ameliorating hippocampal neuroinflammation in depressed rats based on complement component C3/C3aR pathway]. | Zhongguo Zhong Yao Za Zhi | 2025 | 39929641 | PubTator, text mining | PubMed |
| C3AR1 as a target for preeclampsia: from bioinformatics and network pharmacology to experimental validation. | BMC Pregnancy Childbirth | 2025 | 39885406 | PubTator, text mining | PubMed |
| Structural insights into the agonist activity of the nonpeptide modulator JR14a on C3aR. | Cell Discov | 2025 | 39788969 | PubTator, text mining | PubMed |
| CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases. | Gut | 2025 | 39537239 | PubTator, text mining | PubMed |
| Complement Molecule C3a Exacerbates Early Brain Injury After Subarachnoid Hemorrhage by Inducing Neuroinflammation Through the C3aR-ERK-P2X7-NLRP3 Inflammasome Signaling Axis. | Inflammation | 2025 | 39528767 | PubTator, text mining | PubMed |
| Clinical Significance of Complement and Coagulation Cascades Genes for Patients With Acute Lymphoblastic Leukemia. | Int J Lab Hematol | 2025 | 39523585 | PubTator, text mining | PubMed |
| Genetic variants contribute to modulation of renal function in patients with immune thrombotic thrombocytopenic purpura. | Blood Vessel Thromb Hemost | 2024 | 40765928 | PubTator, text mining | PubMed |
| The Role of Complement Component 3 (C3) in Psoriasis. | Curr Mol Pharmacol | 2024 | 40148302 | PubTator, text mining | PubMed |
| A cellular triad for linking cardiac niche to regeneration. | Cell Regen | 2024 | 39653982 | PubTator, text mining | PubMed |
| Complement System and Adhesion Molecule Skirmishes in Fabry Disease: Insights into Pathogenesis and Disease Mechanisms. | Int J Mol Sci | 2024 | 39596318 | PubTator, text mining | PubMed |
| The C3-C3aR axis modulates trained immunity in alveolar macrophages. | bioRxiv | 2024 | 39554000 | PubTator, text mining | PubMed |
| The complement C3a/C3aR pathway is associated with treatment resistance to gemcitabine-based neoadjuvant therapy in pancreatic cancer. | Comput Struct Biotechnol J | 2024 | 39469671 | PubTator, text mining | PubMed |
| C3a Mediates Endothelial Barrier Disruption in Brain-Derived, but Not Retinal, Human Endothelial Cells. | Int J Mol Sci | 2024 | 39457022 | PubTator, text mining | PubMed |
| Shaping the immune landscape: Multidimensional environmental stimuli refine macrophage polarization and foster revolutionary approaches in tissue regeneration. | Heliyon | 2024 | 39296009 | PubTator, text mining | PubMed |
| Complement 3a induces the synapse loss via C3aR in mitochondria-dependent NLRP3 activating mechanisms during the development and progression of Alzheimer's disease. | Neurosci Biobehav Rev | 2024 | 39218048 | PubTator, text mining | PubMed |
| Hypoxia-induced complement component 3 promotes aggressive tumor growth in the glioblastoma microenvironment. | JCI Insight | 2024 | 39172519 | PubTator, text mining | PubMed |
| Comprehensive investigation of tumor immune microenvironment and prognostic biomarkers in osteosarcoma through integrated bulk and single-cell transcriptomic analysis. | Front Immunol | 2024 | 39108264 | PubTator, text mining | PubMed |
| Exploring the Role of Neutrophil-Related Genes in Osteosarcoma via an Integrative Analysis of Single-Cell and Bulk Transcriptome. | Biomedicines | 2024 | 39062086 | PubTator, text mining | PubMed |
| Characterization of cuproptosis signature in clear cell renal cell carcinoma by single cell and spatial transcriptome analysis. | Discov Oncol | 2024 | 39044005 | PubTator, text mining | PubMed |
| A review of progress on complement and primary membranous nephropathy. | Medicine (Baltimore) | 2024 | 39029058 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/719/papers?page=7